PremiumCompany AnnouncementsNanoVibronix Announces $10M Public Offering Completion NanoVibronix Delays Q1 2025 Financial Report NanoVibronix announces results from UroShield case series PremiumThe FlyNanoVibronix announces UroShield health service study data published NanoVibronix Inc trading halted, news pending NanoVibronix announces 1 for 11 reverse stock split PremiumThe FlyNanoVibronix completes pilot phase of UroShield study at University of Michigan NanoVibronix Strengthens Governance with Key Approvals NanoVibronix Presents at Annual Stockholders Meeting